Original price was: ₹191.66.₹180.00Current price is: ₹180.00.
Okamet GM 502 Tablet
Company: Cipla Ltd.
Salt Composition: Glimepiride (2mg) + Metformin Hydrochloride (500mg, Sustained Release)
15.0 Tablet pr in 1 strip
Description
Okamet GM 502 Tablet is a combination oral antidiabetic medicine manufactured by Cipla Ltd. It contains Glimepiride 2mg and Metformin Hydrochloride 500mg (Sustained Release). This medicine is prescribed for the management of Type 2 Diabetes Mellitus when diet, exercise, and single therapy are not sufficient to control blood sugar levels.
How Okamet GM 502 Works
-
Glimepiride (2mg): A sulfonylurea that stimulates the pancreas to release more insulin, helping to reduce high blood sugar levels, especially after meals.
-
Metformin SR (500mg): A biguanide that reduces glucose production in the liver, delays absorption of sugar from the intestine, and enhances the body’s sensitivity to insulin. The sustained-release (SR) formulation provides longer-lasting action and reduces stomach irritation compared to immediate-release forms.
Together, these medicines provide complementary effects, giving effective control over both fasting and postprandial (after meal) blood glucose levels.
Uses of Okamet GM 502 Tablet
-
Management of Type 2 Diabetes Mellitus in patients not adequately controlled by lifestyle measures or single-drug therapy.
-
Helps in lowering fasting and post-meal sugar levels.
-
Prevents the risk of diabetes-related long-term complications such as:
-
Diabetic kidney disease (nephropathy)
-
Nerve damage (neuropathy – tingling, numbness, burning pain)
-
Eye damage (retinopathy/vision problems)
-
Cardiovascular diseases such as heart attack and stroke
-
-
Beneficial for patients requiring stronger glucose control with higher Glimepiride strength.
Dosage & Administration
-
Usually taken once daily with the first main meal of the day (preferably breakfast).
-
Swallow the tablet whole with water; do not crush or chew.
-
Dose adjustments depend on blood sugar levels and doctor’s recommendation.
-
Regular monitoring of blood glucose and HbA1c is necessary for effective control.
Precautions
-
Not for use in Type 1 Diabetes or diabetic ketoacidosis.
-
Caution required in patients with kidney or liver problems.
-
Avoid alcohol as it increases the risk of hypoglycemia (low blood sugar) and lactic acidosis.
-
Patients should not skip meals and should always carry a sugar source (like glucose tablets or candy) in case of hypoglycemia.
-
Should be used during pregnancy or breastfeeding only on medical advice.
Possible Side Effects
-
Hypoglycemia (sweating, shakiness, hunger, dizziness, weakness)
-
Stomach upset, nausea, diarrhea, or abdominal discomfort
-
Headache or mild dizziness
-
Long-term use may cause Vitamin B12 deficiency (due to Metformin)
-
Rare but serious: Lactic acidosis (symptoms: muscle pain, breathing difficulty, severe weakness)
Overall Benefit
Okamet GM 502 Tablet provides a powerful dual therapy for Type 2 Diabetes by combining Glimepiride and Metformin SR. It ensures effective blood sugar control throughout the day, lowers the risk of diabetes-related complications, and improves overall quality of life when taken along with a proper diet and exercise routine.






